Healthlead Past Earnings Performance
Past criteria checks 2/6
Healthlead has been growing earnings at an average annual rate of 26.5%, while the Consumer Retailing industry saw earnings declining at 0.7% annually. Revenues have been growing at an average rate of 14.3% per year. Healthlead's return on equity is 7.7%, and it has net margins of 4.5%.
Key information
26.5%
Earnings growth rate
18.4%
EPS growth rate
| Consumer Retailing Industry Growth | -1.7% |
| Revenue growth rate | 14.3% |
| Return on equity | 7.7% |
| Net Margin | 4.5% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses BreakdownBeta
How Healthlead makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 1,659 | 75 | 307 | 0 |
| 30 Sep 23 | 1,604 | 79 | 297 | 0 |
| 30 Jun 23 | 1,590 | 94 | 280 | 0 |
| 31 Mar 23 | 1,552 | 101 | 265 | 0 |
| 31 Dec 22 | 1,538 | 118 | 250 | 0 |
| 30 Sep 22 | 1,447 | 106 | 228 | 0 |
| 30 Jun 22 | 1,400 | 100 | 220 | 0 |
| 31 Mar 22 | 1,332 | 95 | 204 | 0 |
| 31 Dec 21 | 1,216 | 80 | 191 | 0 |
| 30 Sep 21 | 1,196 | 71 | 189 | 0 |
| 31 Mar 21 | 1,030 | 44 | 175 | 0 |
| 01 Jan 21 | 1,080 | 52 | 175 | 0 |
| 31 Dec 19 | 935 | 22 | 903 | 0 |
| 31 Dec 18 | 791 | 0 | 139 | 0 |
| 31 Dec 17 | 701 | -9 | 123 | 0 |
Quality Earnings: HL-R has high quality earnings.
Growing Profit Margin: HL-R's current net profit margins (4.5%) are lower than last year (7.7%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: HL-R's earnings have grown significantly by 26.5% per year over the past 5 years.
Accelerating Growth: HL-R's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: HL-R had negative earnings growth (-36.8%) over the past year, making it difficult to compare to the Consumer Retailing industry average (8.3%).
Return on Equity
High ROE: HL-R's Return on Equity (7.7%) is considered low.